The following data is part of a premarket notification filed by Trace America, Inc. with the FDA for Trace Reagent Line For The Cobas Mira.
Device ID | K973869 |
510k Number | K973869 |
Device Name: | TRACE REAGENT LINE FOR THE COBAS MIRA |
Classification | Nadh Oxidation/nad Reduction, Alt/sgpt |
Applicant | TRACE AMERICA, INC. 7260 NORTH WEST 58TH ST. Miami, FL 33166 |
Contact | David Johnston |
Correspondent | David Johnston TRACE AMERICA, INC. 7260 NORTH WEST 58TH ST. Miami, FL 33166 |
Product Code | CKA |
Subsequent Product Code | CDQ |
Subsequent Product Code | CEK |
Subsequent Product Code | CGX |
Subsequent Product Code | CHH |
Subsequent Product Code | CIG |
Subsequent Product Code | CIT |
Subsequent Product Code | JFJ |
Subsequent Product Code | JGY |
Subsequent Product Code | JIY |
Subsequent Product Code | JMO |
Subsequent Product Code | KHS |
Subsequent Product Code | KNK |
CFR Regulation Number | 862.1030 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 1997-09-24 |
Decision Date | 1998-01-07 |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00845275003031 | K973869 | 000 |
00845275002973 | K973869 | 000 |
00845275000351 | K973869 | 000 |
00845275000047 | K973869 | 000 |